The Supreme Court and reproductive medicine, 2024.

The US Supreme Court's most recent Term illustrates the considerable influence the Court has on the practice of reproductive health providers and their patients. Cases included the availability of mifepristone and emergency-care abortions. In addition, the Court substantially changed its deference to administrative agencies (e.g., Food and Drug Administration, Centres for Medicare & Medicaid Services, and United States Department of Homeland Security) which will affect medical practice. National organizations of physicians and reproductive health providers (e.g., American College of Obstetricians and Gynecologists, American Society for Reproductive Medicine, and the Pro-Life Obstetricians and Gynecologists) now play an active role in communicating with the Court to affect the outcome of cases.